Today (September 11), the Lasker Foundation announced this year’s award winners. Jesús (Tito) González, an ion channel biologist formerly at Vertex Pharmaceuticals, Paul Negulescu, a cell biologist at ...
- ALYFTREK™ is approved for patients 6 years and older with at least one responsive mutation, including 31 additional mutations not responsive to other CFTR modulator therapies - - In head-to-head ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results